| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 7 | |
| #2 | United States | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Argentina | 1 | |
| #5 | Australia | 1 | |
| #6 | Brazil | 1 | |
| #7 | Canada | 1 | |
| #8 | Israel | 1 | |
| #9 | Singapore | 1 | |
| #10 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kaldor Stephen W | 16 |
| #2 | Kanouni Toufike | 16 |
| #3 | Murphy Eric A | 14 |
| #4 | Tyhonas John | 12 |
| #5 | Arnold Lee D | 10 |
| #6 | Arnold Lee | 5 |
| #7 | Stephen W Kaldor | 1 |
| #8 | John Tyhonas | 1 |
| #9 | Toufike Kanouni | 1 |
| #10 | Eric A Murphy | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021081375A1 | Inhibitors of raf kinases | |
| WO2021011796A1 | Inhibitors of cyclin-dependent kinases | |
| WO2020236524A1 | Inhibitors of fibroblast growth factor receptor kinases | |
| US2020347052A1 | Inhibitors of RAF kinases | |
| WO2020198058A1 | Inhibitors of raf kinases | |
| US2020024266A1 | Inhibitors of cyclin-dependent kinases | |
| WO2019213403A1 | Inhibitors of cyclin-dependent kinases |